Secondly, due to the high cost associated with pan-cancer gene targeted sequencing (thousands of RMB per sample), in contrast to the comparatively lower cost of detecting hotspot mutations of single gene using multiplex-PCR and deep sequencing (only hundreds RMB per sample), investigating AR mutations was undertaken as the primary focus of our expanded sample experiment. The gene discussed is AR; the disease is cancer.